Search
Generic filters
Exact matches only
Filter by Custom Post Type

Alnylam Picks Jacobs to Help Construct $200m RNAi Manufacturing Plant in MA

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn

Genetic medicine firm Alnylam has chosen Jacobs Engineering Group to provide engineering services for its manufacturing plant in Norton, Massachusetts. The plant should be operational by 2018. The $200 million factory will produce the RNAi (interfering RNA) medicines for which the company is known. The genetic therapeutics are principally used at this time to repair liver dysfunction at the genetic level.  The facility will cover 200,000 square feet. A second manufacturing plant is in the planning stage should the drug therapy prove popular in its target patient market. Read more…

SUBSCRIBE TO THE JOBSITE NEWSLETTER

Catch up on important industry insights and best practices each week with the Jobsite newsletter.

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn

More to explore